ACTILYSE subst sèche 50 mg c solv flac

7680483130192 CH-48313 B01AD02 06.05.0.
ACTILYSE subst sèche 50 mg c solv flac
ACTILYSE subst sèche 50 mg c solv flac
ACTILYSE subst sèche 50 mg c solv flac
1 / 3
google

Details

Product number
4831302
CPT
-
Packaging group
1 x 50
Unit
mg
Composition
Praeparatio cryodesiccata: alteplasum ADNr 50 mg, argininum, acidum phosphoricum, polysorbatum 80, pro vitro. Solvens: aqua ad iniectabile.

Articles (1)

Actilyse 50mg, Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung
Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung
1 x 50
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
12/09/2025
Professional SmPC
Français
12/09/2025
Professional SmPC
Italien
12/09/2025

Detailed composition

Substance Quantity Type Category
SOLV
- Substance HNIDK
PRC
50.0 MG Substance Wirkstoff (Principe actif)
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK

Authorization holder

Boehringer Ingelheim (Schweiz) GmbH

4057 Basel

Authorization information

Swissmedic authorization number
48313
Drug name
Actilyse, Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung
Galenic form
PULMK
ATC Code
B01AD02
Authorization status
Z
Dispensation category
B
First authorization
19/09/1988
Authorization expiration date
31/12/9999
IT number
06.05.0.
Domain
Human medicine
Field of application
Thrombolytische Therapie bei akutem Herzinfarkt, akuter massiver Lungenembolie, akutem ischämischem Hirnschlag

Packaging details

Description (FR)
ACTILYSE subst sèche 50 mg c solv flac
Description (DE)
ACTILYSE Trockensub 50 mg c Solv Durchstf
Market launch
19/09/1988
Narcotic (BTM)
No

Other packaging sizes

ACTILYSE subst sèche 20 mg c solv flac
1 x 20 MG
View
ACTILYSE subst sèche 10 mg c solv flac
1 x 10 MG
View